Fitbone has of course a much bigger failure rate than what Witthenstein claims.
We have more known cases that it failed than 0.12 % even if there have been manufactured 10.000 fitbone nails (which I don't believe).
Also Wittgenstein should better refund the patients and fix the very big failure rate of fitbone than doing funny claims like 0,12%.
That said, fitbone is inferion in everything to precise 2. Weight bearing abilities, inability for reverse lengthening, failure rate etc are things that precise 2 is superior by far.
The only benefit of fitbone is the cheaper price but the difference is not much to prefer it taking in mind all the above I mentioned.
There appears to be a misconception, very common amongst non engineering or technical background persons, that the failure rate is the number of failures divided by the population. However, this is incorrect, as the the term failure
rate, implies. The failure rate, in it's simplest format, is determined by the number of failures x time interval of sampling / population x time in operation of population. As an example a car that fails after 5 years does not have the same failure rate as one which fails when brand-new.
Fitbone was invented by Dr. Baumgart and Dr. Betz in 1992, and the clinical results were described in Baumgart et al 1997.
https://www.ncbi.nlm.nih.gov/pubmed/9345218In 2005, in a study of 150 patients, Baumgart reported failures in 3% of the implants.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235314/#CIT0003Over the last 25 years, the Fitbone has undergone many updates and the present version has been implanted in at least 2000 cases worldwide.
https://obgynkey.com/motorized-intramedullary-lengthening-an-emerging-technology-for-limb-length-and-deformity-correction/I cannot give details of the 0,12% failure rate as I signed a confidentiality agreement with Wittenstein.
For those with an open mind, here are some studies on Precice,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253187/https://www.ncbi.nlm.nih.gov/pubmed/28439819